e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Genetics and genomics in asthma and COPD: prediction and personalised medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis?
D.S. Postma (Groningen, The Netherlands)
Source:
Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Session:
Genetics and genomics in asthma and COPD: prediction and personalised medicine
Session type:
Symposium
Number:
3059
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D.S. Postma (Groningen, The Netherlands). How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis?. Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
What is the optimal management option for occupational asthma?
Source: Eur Respir Rev 2012; 21: 97-104
Year: 2012
Effect of autoimmune diseases on risk and survival in histology-specific lung cancer
Source: Eur Respir J 2012; 40: 1489-1495
Year: 2012
Known and emerging risk factors for asthma development: is prevention possible?
Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient
Year: 2015
No identifiable risk factors for lung remodelling in children with difficult to treat asthma
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010
The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories
Source: Eur Respir J, 58 (5) 2004656; 10.1183/13993003.04656-2020
Year: 2021
Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
Using community pharmacy to identify patients at risk of poor asthma control and potential contributory factors
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011
Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention
Source: Virtual Congress 2020 – Reducing the burden of asthma
Year: 2020
Occupational risk factors may be of importance to define populations suitable to screening of lung cancer
Source: Annual Congress 2011 - Work, the environment and respiratory disease
Year: 2011
Knowledge and attitudes of TB patients about risk factors which contribute the genesis of their disease
Source: Eur Respir J 2005; 26: Suppl. 49, 417s
Year: 2005
Frequency, severity and risk factors of drug-induced liver injury during treatment of new tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
Is asthma a risk factor for severe outcomes in COVID 19?
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021
Work-related asthma: frequent in the population but why so rarely diagnosed?
Source: Annual Congress 2005 - Occupational asthma
Year: 2005
The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Childhood factors that predict asthma in young adulthood
Source: Eur Respir J 2004; 23: 66-70
Year: 2004
How can we improve asthma management?
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005
Pathogenesis of occupational asthma, including genetic factors
Source: Annual Congress 2005 - Occupational asthma
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept